Some embodiments of the present invention relate generally to skin rejuvenation, and particularly to methods and apparatus for wrinkle reduction.
Skin, the body's largest organ, is composed of multiple layers. The outer layer, epidermis, is divided into several sublayers; the outermost layer is termed stratum corneum epidermidis. The stratum corneum is generally a non-innervated cell layer consisting of mainly large, dead cells that lack nuclei. Beneath the epidermis, lies the dermis skin layer, which is tightly connected to the epidermis.
A major structural component of the skin is collagen, a fibrous protein, which contributes to skin strength and elasticity. As such, collagen formation and remodeling lead to changes in mechanical properties of the skin such as texture and resilience. Typically, collagen plays an important role in the regeneration of epidermal tissue in wounded skin. Collagen is produced during the wound healing process, thus increasing the tensile strength of a wound.
Collagen contraction, or thermal shrinkage of collagen, occurs by the dissociation of heat-sensitive bonds of the collagen molecule. Thermal denaturing of collagen results in a tightening effect of the skin. In contrast, age-related degradation of collagen leads to sagging of the skin and the formation of wrinkles. Many wrinkles appear on exposed areas of the skin, e.g., the face, the neck and the forearms. These visible effects of aging of the skin are disturbing to some individuals, and therefore methods for rejuvenation of maturing or damaged skin are of interest.
U.S. Pat. No. 6,461,354 to Olsen et al. describes systems and methods for selectively applying electrical energy to a target location on an external body surface, such as for skin tissue removal and/or collagen shrinkage in the epidermis or dermis, e.g., the removal of pigmentations, vascular lesions (e.g., leg veins), scars, tattoos, etc., and for other surgical procedures on the skin, such as tissue rejuvenation, cosmetic surgery, wrinkle removal, hair removal and/or transplant procedures. The described system and methods apply high frequency (RF) electrical energy to one or more electrode terminals adjacent an external body surface, such as the outer surface of the skin, to remove and/or modify the structure of tissue structures within the skin. Depending on the specific cosmetic procedure, the described system and methods may be used to: (1) volumetrically remove tissue or hair (i.e., ablate or effect molecular dissociation of the tissue structure); (2) separate a tissue layer from an underlying tissue layer so that the tissue layer can be removed; (3) shrink or contract collagen connective tissue; and/or (4) coagulate blood vessels underlying the surface of the skin.
U.S. Pat. No. 6,381,498 to Knowlton describes a method and apparatus that applies radiant energy through the skin to underlying collagen tissue, and is described as not substantially modifying melanocytes and other epithelial cells in the epidermis. A membrane is adapted to receive an electrolytic solution and become inflated to substantially conform to a contacting exterior surface of the membrane to a skin layer. The membrane includes a cooling lumen for receiving cooling fluid. One or more thermal electrodes positioned in the membrane transfers thermal energy to the electrolytic solution. The electrolytic solution and cooling fluid is described as creating a reverse thermal gradient from the skin surface to the underlying collagen tissue. A thermal power source is coupled to the thermal electrodes, and a source of electrolytic solution is coupled to the membrane.
US 2006/0036300 to Kreindel describes a method of lipolysis. The method comprises deforming a region of skin so that the region of skin protrudes from surrounding skin. One or more radio frequency (RF) electrodes are positioned on the protruding region of skin so as to generate an electrical current through adipose tissue in the protruding region of skin when a voltage is applied to the electrode or electrodes. A voltage is then applied to the electrode or electrodes so as to deliver sufficient RF energy to the protruding region of skin to damage subcutaneous adipose tissue. The described method may be used, for example, to achieve a reduction in body weight, cellulite reduction, loose skin reduction, wrinkle treatment, body surface tightening, skin tightening, and collagen remodeling.
U.S. Pat. No. 6,684,107 to Binder describes a system for reducing wrinkles on human skin that utilizes an electrode to conduct a microcurrent through the surface of the wrinkle into the underlying dermal layer. The electrode is moved in multiple passes along the length of the wrinkle, with the electrode in contact with the surface of the wrinkle while generating a periodically repeating microcurrent having a peak amplitude in the range of 10-40 microamps, a peak current density in the range of 10-50 microamps/cm.sup.2, and a frequency in the range of 5-15 Hz. The electrode device is described as self-contained in a battery-containing, cordless case from which a contact electrode protrudes. A hand-engaging second electrode on the surface of the case completes a conductive path through the user's body.
U.S. Pat. No. 6,148,232 to Avrahami describes a device for ablating the stratum corneum epidermidis of a subject, including a plurality of electrodes, which are applied to the subject's skin at respective points. A power source applies electrical energy between two or more of the plurality of electrodes, in order to cause ablation of the stratum corneum primarily in an area intermediate the respective points.
U.S. Pat. No. 6,611,706 to Avrahami describes a device for facilitating transdermal passage of a substance through skin on the body of a subject. The device preferably includes an electrode and a control unit. In a preferred embodiment, the control unit is adapted to drive the electrode to apply to the skin a current capable of ablating stratum corneum epidermidis of the skin, so as to facilitate transdermal passage of the substance. The control unit detects generation of at least one spark responsive to application of the current, and modifies a parameter of the current responsive to detecting the generation of the at least one spark.
U.S. Pat. No. 6,708,060 to Avrahami describes a device for treating skin on the body of a subject. The device includes a plurality of electrodes, which are adapted to be placed in contact with the skin and then moved across the skin while maintaining electrical contact with the skin. The device additionally includes a power source, which is adapted to apply a current between two or more of the plurality of electrodes at the same time as the electrodes are being moved across the skin.
Reliant Technologies (California, US) distributes the Fraxel family of cosmetic products, which includes three fractional lasers that produce two non-ablative treatments and one ablative treatment.
The following patent and patent applications may be of interest:
US 2005/0003518 to Avrahami et al.
US 2005/0119605 to Sohn
US 2005/0187497 to Nguyen
US 2006/0089688 to Panescu
US 2007/0270732 to Levine
US 2007/0287949 to Levine et al.
US 2007/0292445 to Levine
US 2008/0114281 to Birchall et al.
U.S. Pat. No. 5,569,242 to Lax et al.
U.S. Pat. No. 5,746,746 to Garito et al
U.S. Pat. No. 6,026,327 to Dervieux
U.S. Pat. No. 6,597,946 to Avrahami et al.
U.S. Pat. No. 6,711,435 to Avrahami
U.S. Pat. No. 7,123,957 to Avrahami
U.S. Pat. No. 7,335,377 to Stern
U.S. Pat. No. 7,395,111 to Levine et al.
In some applications of the present invention, an apparatus and a method for reducing a wrinkle on a skin surface is provided. An array of electrodes coupled to an energy source is positioned on the wrinkle. The electrodes remain at the same sites on the skin surface for at least two successive periods of time. During the first period of time, energy from the energy source is applied to drive the electrodes to apply radio frequency (RF) current at a first voltage. The current applied at the first voltage is capable of locally ablating the epidermal tissue (and typically superficial dermal tissue) in close proximity to the electrodes. Ablation of the epidermal tissue (and typically superficial dermal tissue) by the applied RF current generates micro-channels through the epidermis (and typically superficial dermis). The formation of the micro-channels induces natural body fluid to enter the micro-channels. Whereas during ablation the resistance between electrodes increases, the resistance subsequently decreases when body fluid enters the micro-channels. During the subsequent, second time period, energy from the energy source is applied to drive the electrodes to apply current at a second voltage, lower than the first voltage. The current applied at the second voltage is sufficient to continuously heat the fluid within the micro-channels and underlying tissue, but generally does not cause further ablation.
The inventors hypothesize that the ablation of epidermal tissue (and typically superficial dermal tissue) with subsequent heating of underlying tissue leads to collagen regeneration and remodeling, resulting in skin rejuvenation. The first phase of RF application ablates micro-channels in the epidermal layer (and typically superficial dermal layer) of the skin in close proximity to the electrodes, as described hereinabove. The ablation of the micro-channels triggers the initiation of a wound healing process in the skin, in which production of collagen is induced. The second phase of lower voltage, non-ablating current application heats the natural body fluid present within the micro-channels, leading to the controlled heating of underlying collagen tissue, causing thermally-mediated collagen contraction. The effect of the combined ablation and heating method of these applications of the present invention is skin tightening and wrinkle reduction. It is noted that although a wound healing process is initiated, ablation of micro-channels into the epidermis (and typically superficial dermis), as provided herein, generally does not cause pain to a subject.
The term “micro-channel,” as used in the context of the present patent application and in the claims, refers to a pathway generally extending from the surface of the skin through at least the epidermis. Such micro-channels are formed due to local power dissipation leading to ablation of the epidermis (and typically superficial dermis) when an electric field of sufficient magnitude is applied to a small area of the skin, in contact with the electrodes, for a sufficient period of time.
There is therefore provided, in accordance with some applications of the invention, a method for reducing a wrinkle on a skin surface, including:
identifying a person having a skin surface with a wrinkle;
in response to identifying the person, positioning at respective sites on the skin surface an array of electrodes coupled to an energy source; and
while the electrodes are at the respective sites:
In some applications, applying energy during the first time period includes applying the energy for 1-20 ms.
In some applications, applying energy during the second time period includes applying the energy for at least 1 second.
In some applications, applying energy during the second time period includes initiating applying the energy through a given electrode during the second time period at least 10 ms after application of energy through the given electrode during the first time period.
In some applications, applying energy during the second time period includes applying only non-ablating energy during the second time period.
In some applications, applying energy during the first time period includes setting a voltage of the energy applied during the first time period to be 150-350 V base-to-peak.
In some applications, applying energy during the second time period includes setting a voltage of the energy applied during the second time period to be 10-200 V base-to-peak.
In some applications, applying energy during the second time period includes setting a voltage of the energy applied during the second time period to be 10-100 V base-to-peak.
In some applications, applying energy during the first time period includes setting a frequency of the energy applied during the first time period to be 50-500 kHz.
In some applications, applying energy during the second time period includes setting a frequency of the energy applied during the second time period to be 50-500 kHz.
In some applications, applying energy during the first time period includes ablating micro-channels in the epidermal layer.
In some applications, applying energy during the second time period includes initiating application of the energy during the second time period subsequently to filling of the micro-channels with body fluid.
There is further provided, in accordance with some applications of the present invention, apparatus for reducing a wrinkle on a skin surface, including:
an array of electrodes configured to be placed on the skin surface; and
an energy source coupled to the array of electrodes and configured to apply energy to drive the electrodes to apply ablating current at a first voltage during a first period of time and to apply non-ablating current at a second voltage, lower than the first voltage, during a second period of time.
In some applications, the energy source is configured to apply energy for 1-20 ms during the first time period.
In some applications, the energy source is configured to apply energy for at least 1 second during the second time period.
In some applications, the energy source is configured to apply energy, during the second time period, through a given electrode at least 10 ms after application of energy through the given electrode during the first time period.
In some applications, the energy source is configured to convey to the electrodes 150-350 V base-to-peak during the first period of time.
In some applications, the energy source is configured to convey to the electrodes 10-200 V base-to-peak during the second period of time.
In some applications, the energy source is configured to convey to the electrodes 10-100 V base-to-peak during the second period of time.
In some applications, the energy source is configured to apply energy at a frequency of 50-500 kHz during the first time period.
In some applications, the energy source is configured to apply energy at a frequency of 50-500 kHz during the second time period.
In some applications, the array of electrodes includes at least 10 electrodes.
In some applications, the array of electrodes includes at least 50 electrodes.
In some applications, the electrodes of the array are arranged in a 2×n rectangular array.
In some applications, the array of electrodes includes electrodes, each electrode 60-80 um in diameter.
In some applications, the array of electrodes includes electrodes, each electrode 50-400 um in length.
In some applications, the array of electrodes includes electrodes, each electrode 100-250 um in length.
In some applications, the array of electrodes includes electrodes generally evenly spaced in the array, the distance between adjacent electrodes being 0.5-1.5 mm.
In some applications, the energy source is configured to apply energy capable of ablating micro-channels in an epidermal layer of the skin during the first period of time.
In some applications, the energy source is configured to initiate application of energy subsequently to filling of the micro-channels with body fluid, during the second period of time.
There is yet further provided, in accordance with some applications of the present invention, apparatus for reducing a wrinkle on a skin surface, including:
an array of at least 10 electrodes, each electrode at least 150 um in length, configured to be placed on the skin surface; and
an energy source coupled to the array of electrodes and configured to apply energy to drive the electrodes to apply 50-500 kHz current capable of ablating an epidermis layer of the skin.
In some applications, the array includes at least 100 electrodes.
In some applications, the electrodes of the array are arranged in a 2×n rectangular array.
In some applications, the electrodes of the array are arranged in an m×n rectangular array, n being at least four times greater than in.
In some applications, each electrode is 60-80 um in diameter.
In some applications, the array of electrodes includes electrodes generally evenly spaced in the array, the distance between adjacent electrodes being 0.5-1.5 mm.
There is also provided, in accordance with some applications of the present invention, a method for reducing a wrinkle on a skin surface, including:
identifying a person having a skin surface with a wrinkle;
in response to identifying the person, positioning at respective sites on the skin surface at least 10 electrodes coupled to an energy source; and
ablating an epidermal layer of the skin by applying energy from the energy source to drive the electrodes to apply 50-500 kHz current.
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
Array 44 is typically 0.5-2 cm2 (e.g., 0.96 cm2), and typically comprises 10-1000 electrodes, e.g., 50-250 electrodes. In all experiments described herein, array 44 comprises 144 electrodes. For some applications (e.g., those used in the experiments described herein), array 44 is arranged as an n×n array, i.e., a square array of electrodes. For other applications, e.g., where it is desired to primarily apply energy in a series of applications along the length of a wrinkle (and to a lesser extent to surrounding tissue), a long, thin, rectangular array is utilized, e.g., an m×n array, where m is typically 2, 3, 4, 5, or 6, and n is typically between 10 and 30, or between 30 and 100. For example, the array may be a 2×10 array. For these applications, n is typically at least four times greater than m (e.g., at least eight times greater than m).
Each electrode 60 is typically 60 um-80 um in diameter and 50 um-400 um in length, e.g., 100-250 um in length, in order to reach the epidermal tissue (and typically superficial dermal tissue). Array 44 is typically snapped on to a housing of apparatus 40 prior to use and ejected after use.
The distance between adjacent electrodes is typically 0.5-1.5 mm, and the electrodes are typically generally evenly spaced in the array. With an array of small diameter electrodes, which are typically generally evenly-spaced electrodes, and with no particular effort by the operator of the apparatus, generally uniform heating of the skin under array 44 is obtained, particularly during the second time period of energy application (described hereinbelow).
Control unit 48 (
Reference is made to
When apparatus 40 drives a sufficient amount of energy through the epidermis (and typically superficial dermis), during the first time period, these skin layers are ablated by the energy dissipating through them. Each individual electrode typically applies this current at a current of 1-20 mA. Typically, 2-12 electrodes (e.g., four electrodes) are simultaneously driven to drive the RF current into the skin, resulting in a correspondingly higher total instantaneous current (e.g., 4-80 mA). The remaining electrodes in array 44 typically serve as return electrodes, and due to their greater number, the return electrodes produce substantially lower current densities in the skin. This ablation creates micro-channels 50, i.e. physical pores in the epidermis (and typically superficial dermis). Micro-channels 50 are accurately reproducible as well as typically small and not visible to a naked eye. Depending on local skin conditions and the current protocol used, the micro-channels are typically 40-100 um in diameter, and 50-400 um (e.g., 30-200 um) in depth.
When each micro-channel 50 has formed in response to current flow by the electrodes, it remains an empty pore until body fluid permeates it. Typically, a given micro-channel 50 is filled by natural body fluid within approximately 30 ms after formation of the micro-channel has occurred. Ablation of micro-channels 50 generally does not cause pain or substantial trauma to skin layers underlying the superficial dermis. Although any wound caused by ablation of the skin is minimal, a natural process of wound healing is induced by formation of micro-channels 50. Production of collagen, which occurs naturally as part of wound healing, leads to a smoother, elastic skin appearance.
Reference is made to
In accordance with a protocol for the first and second time periods, ablation through a given electrode, or small group of electrodes (e.g., four electrodes) is performed during the first time period for that subset of one or more electrodes. Then, another subset of one or more electrodes ablates, during a first time period for that subset of electrodes. This process is repeated until typically substantially all of the electrodes have applied ablating energy to the skin. Subsequently, in the second time period, current is applied at a lower voltage through all of the electrodes, in order to induce uniform heating across the area of skin under array 44. The current driven by energy source 46 during the second time period is typically (but not necessarily) less than 100 mA, and is usually about 10-50 mA. The current driven through any one electrode during the second time period is typically 0.1-1 mA. For some applications, e.g., when array 44 has a smaller number of electrodes, or not all of the electrodes are applying current simultaneously, the current driven through any one electrode may be 1-10 mA.
In some applications, the second period of time is initiated on an electrode-by-electrode basis or a subset-by-subset basis, typically at least 10 ms from the termination of the first time period at any given electrode. For example, each electrode, or small subset of electrodes, may have its own first and second time periods, before another electrode or subset of electrodes has its first time period. For some applications, a first subset of one or more of the electrodes are applying energy in accordance with a first time period protocol, while another subset of one or more electrodes are applying energy in accordance with a second time period protocol.
Typically, in at least one operational mode of apparatus 40, the number n2 of electrodes applying non-ablating energy during any given second time period is higher than the number n1 of electrodes that apply ablating energy during any given first time period. For example, n2 is typically at least 3 or 10 times higher than n1.
The duration of current application during the second time period is typically 1-30 seconds, or 30-200 seconds. The energy applied during the second time period is non-ablating, but typically sufficient to heat body fluid 54 present within micro-channels 50 to a temperature suitable for inducing ongoing changes to collagen. In an experiment, an array 44 of 144 electrodes, 70 um in length, applied 100 kHz current to a volunteer during the first time period for 7 ms at 200 V base-to-peak, in order to ablate at least a portion of the epidermis, and produce micro-channels. During the second time period, array 44 was maintained at the same place as during the first time period, and applied 100 kHz current for approximately 20 seconds, at 80 V base-to-peak. The volunteer reported no unpleasant sensation due to current application during either period. In other experiments described hereinbelow, similar first-time-period protocols were used, without a second time period, and produced measurable wrinkle reduction. In this first and second time period experiment, no measurements were made of wrinkle reduction.
Heating body fluid 54 within micro-channels 50 leads to the controlled heating of underlying collagen tissue, causing thermally-mediated collagen contraction. Thermally-mediated collagen contraction, or shrinkage, typically results in a tightening effect of the skin. Skin tightening and wrinkle reduction are the synergistic effect of the ablation and lower-temperature heating methods of these embodiments of the present invention.
Typically, the use of apparatus 40 results in skin rejuvenation and wrinkle reduction.
In experiments described hereinbelow, performed by the inventors using a version of apparatus 40 that only ablates and does not utilize heating during the second time period, ablation of micro-channels 50 was found to trigger a wound healing process in the skin, in which collagen formation is naturally induced.
The following examples are provided in order to illustrate the effects of embodiments of the present invention.
As shown in
Table I is a table representing skin analysis of eight subjects following treatment by the method and apparatus described herein for electrical skin rejuvenation, in accordance with some applications of the present invention, using the protocol described hereinabove with reference to
In this set of experiments, forearm skin biopsy samples were taken from treated and non-treated skin surfaces of eight subjects. The subjects were divided into two age groups. The younger age group (35-42 y) was designated group A, and the older age group (47-51 y) was designated group B. The skin samples were analyzed for collagen and elastin content, as determined by collagen and elastin staining; and epidermal cell proliferation, as determined by a specific marker for proliferating cells (Ki67). As shown in Table I, all subjects in group B showed increased collagen fiber content and increased skin cell proliferation in response to treatment by the method and apparatus for skin rejuvenation, in accordance with some applications of the present invention. Additionally, 75% of the subjects in group B, showed an increase in elastin fiber content. In contrast, the collagen fiber content of subjects in group A was not altered by the treatment. In addition, only 25% of the subjects in group A showed increased elastin content and 50% exhibited increased cell proliferation in response to treatment. Separate results (not shown) demonstrated that pain, erythema, and edema produced during the study were acceptable in each of the test subjects.
Trans Epidermal Water Loss (TEWL) was analyzed following treatment of skin surfaces of foreheads and forearms of subjects. The skin surfaces were treated with the method and apparatus for skin rejuvenation, in accordance with some applications of the present invention. Analysis of the results of the studies preformed on the forearm site show that following the first treatment, TEWL value was significantly higher than the TEWL value measured prior to initiation of treatment (as measured with a VapoMeter (Delfin Technologies, Ltd.) (p=0.012) and according to the Wilcoxon signed-ranks test. TEWL values remained significantly elevated for 48 hours to one week following treatment. (Similar results were obtained for the forehead site.)
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application claims the priority of U.S. Provisional Application 61/208,621 to Levin, entitled, “Electrical skin rejuvenation,” filed Feb. 25, 2009, which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IL2010/000149 | 2/22/2010 | WO | 00 | 10/19/2011 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2010/097790 | 9/2/2010 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1430354 | Burdick | Sep 1922 | A |
2088780 | Follese | Aug 1937 | A |
2183726 | Sommer et al. | Feb 1939 | A |
2231095 | Sommer et al. | Feb 1941 | A |
2727132 | Hills | Dec 1955 | A |
2824308 | Duncan | Feb 1958 | A |
2888927 | Fozard | Jun 1959 | A |
3088205 | Ellis | May 1963 | A |
D196532 | Facci | Oct 1963 | S |
4016886 | Doss et al. | Apr 1977 | A |
4174713 | Mehl | Nov 1979 | A |
4182329 | Smit et al. | Jan 1980 | A |
4185632 | Shaw | Jan 1980 | A |
4200104 | Harris | Apr 1980 | A |
4211230 | Woltosz | Jul 1980 | A |
4228931 | Ruscitti et al. | Oct 1980 | A |
4321926 | Roge | Mar 1982 | A |
D269294 | Rakocy et al. | Jun 1983 | S |
D271015 | Geraets | Oct 1983 | S |
D271199 | Geraets | Nov 1983 | S |
4444190 | Mutzhas | Apr 1984 | A |
D274462 | Rakocy et al. | Jun 1984 | S |
4532924 | Auth et al. | Aug 1985 | A |
4550728 | Runyon et al. | Nov 1985 | A |
4553936 | Wang | Nov 1985 | A |
4566454 | Mehl et al. | Jan 1986 | A |
4686986 | Fenyo et al. | Aug 1987 | A |
4753958 | Weinstein et al. | Jun 1988 | A |
4784135 | Blum et al. | Nov 1988 | A |
4844063 | Clark | Jul 1989 | A |
4867682 | Hammesfahr et al. | Sep 1989 | A |
4869584 | Dion | Sep 1989 | A |
5016999 | Williams | May 1991 | A |
5071418 | Rosenbaum | Dec 1991 | A |
5125928 | Parins et al. | Jun 1992 | A |
5169384 | Bosniak et al. | Dec 1992 | A |
5286479 | Garlich et al. | Feb 1994 | A |
5316473 | Hare | May 1994 | A |
5319363 | Welch et al. | Jun 1994 | A |
5348554 | Imran et al. | Sep 1994 | A |
5353798 | Sieben | Oct 1994 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5402697 | Brooks | Apr 1995 | A |
5406340 | Hoff | Apr 1995 | A |
5418130 | Platz et al. | May 1995 | A |
5449378 | Schouenborg | Sep 1995 | A |
5487662 | Kipke et al. | Jan 1996 | A |
5509916 | Taylor | Apr 1996 | A |
5520684 | Imran | May 1996 | A |
5521392 | Kennedy et al. | May 1996 | A |
5564851 | Connely et al. | Oct 1996 | A |
5582476 | Hansen | Dec 1996 | A |
5611793 | Wilson et al. | Mar 1997 | A |
5628771 | Mizukawa et al. | May 1997 | A |
5642997 | Gregg et al. | Jul 1997 | A |
5658148 | Neuberger et al. | Aug 1997 | A |
5674267 | Mir et al. | Oct 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5683380 | Eckhouse et al. | Nov 1997 | A |
5693052 | Weaver | Dec 1997 | A |
5698866 | Doiron et al. | Dec 1997 | A |
5704935 | Pahl et al. | Jan 1998 | A |
5707403 | Grove et al. | Jan 1998 | A |
5718702 | Edwards | Feb 1998 | A |
5722411 | Suzuki et al. | Mar 1998 | A |
5731582 | West | Mar 1998 | A |
5735844 | Anderson et al. | Apr 1998 | A |
5755753 | Knowlton | May 1998 | A |
5769880 | Truckai et al. | Jun 1998 | A |
5810801 | Anderson et al. | Sep 1998 | A |
5814008 | Chen et al. | Sep 1998 | A |
5824023 | Anderson | Oct 1998 | A |
5836999 | Eckhouse et al. | Nov 1998 | A |
5843078 | Sharkey | Dec 1998 | A |
5843143 | Whitehurst | Dec 1998 | A |
5846252 | Mehl, Sr. | Dec 1998 | A |
5868744 | Willmen | Feb 1999 | A |
5871469 | Eggers et al. | Feb 1999 | A |
5871524 | Knowlton | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5919219 | Knowlton | Jul 1999 | A |
5935143 | Hood | Aug 1999 | A |
5949514 | Wargon | Sep 1999 | A |
5954710 | Paolini et al. | Sep 1999 | A |
5961543 | Waldmann | Oct 1999 | A |
5984915 | Loeb et al. | Nov 1999 | A |
5993180 | Westerhof et al. | Nov 1999 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6030384 | Nezhat | Feb 2000 | A |
6053172 | Hovda et al. | Apr 2000 | A |
6056548 | Neuberger et al. | May 2000 | A |
6063108 | Salansky et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6080127 | Li et al. | Jun 2000 | A |
6080391 | Tsuchiya et al. | Jun 2000 | A |
6081934 | Stefanovsky et al. | Jul 2000 | A |
6107326 | Jori | Aug 2000 | A |
6132701 | Perez et al. | Oct 2000 | A |
6148232 | Avrahami | Nov 2000 | A |
6159222 | Yiu | Dec 2000 | A |
6186960 | Tripp et al. | Feb 2001 | B1 |
6187001 | Azar et al. | Feb 2001 | B1 |
6188407 | Smith et al. | Feb 2001 | B1 |
6190609 | Chapman et al. | Feb 2001 | B1 |
6191110 | Jaynes et al. | Feb 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6221095 | Van Zuylen et al. | Apr 2001 | B1 |
6228078 | Eggers et al. | May 2001 | B1 |
6231571 | Ellman et al. | May 2001 | B1 |
6231593 | Meserol | May 2001 | B1 |
6251127 | Biel | Jun 2001 | B1 |
6258319 | Hearst et al. | Jul 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6277116 | Utely et al. | Aug 2001 | B1 |
6280438 | Eckhouse et al. | Aug 2001 | B1 |
6288498 | Cheng | Sep 2001 | B1 |
6308413 | Westerhof et al. | Oct 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6311090 | Knowlton | Oct 2001 | B1 |
6325797 | Stewart et al. | Dec 2001 | B1 |
6343400 | Massholder et al. | Feb 2002 | B1 |
6343933 | Montgomery et al. | Feb 2002 | B1 |
6352535 | Lewis et al. | Mar 2002 | B1 |
6353763 | George et al. | Mar 2002 | B1 |
6360116 | Jackson et al. | Mar 2002 | B1 |
6381497 | Knowlton | Apr 2002 | B1 |
6405090 | Knowlton | Jun 2002 | B1 |
6406157 | Audet | Jun 2002 | B1 |
6413255 | Stern | Jul 2002 | B1 |
6413268 | Hartman | Jul 2002 | B1 |
6416514 | Ein-Gal | Jul 2002 | B1 |
6419674 | Bowser et al. | Jul 2002 | B1 |
6425912 | Knowlton | Jul 2002 | B1 |
6430446 | Knowlton | Aug 2002 | B1 |
6433343 | Cimino et al. | Aug 2002 | B1 |
6436051 | Morris et al. | Aug 2002 | B1 |
6438424 | Knowlton | Aug 2002 | B1 |
6440121 | Weber et al. | Aug 2002 | B1 |
6452912 | Leem | Sep 2002 | B1 |
6453202 | Knowlton | Sep 2002 | B1 |
6461354 | Olsen et al. | Oct 2002 | B1 |
6461378 | Knowlton | Oct 2002 | B1 |
6461567 | Hearst et al. | Oct 2002 | B1 |
6462070 | Hasan et al. | Oct 2002 | B1 |
6470216 | Knowlton | Oct 2002 | B1 |
6471716 | Pecukonis | Oct 2002 | B1 |
6482201 | Olsen et al. | Nov 2002 | B1 |
6482204 | Lax et al. | Nov 2002 | B1 |
6487447 | Weimann et al. | Nov 2002 | B1 |
6493940 | Westerhof et al. | Dec 2002 | B2 |
6494900 | Salansky et al. | Dec 2002 | B1 |
6497702 | Bernaz | Dec 2002 | B1 |
6508813 | Althshuler | Jan 2003 | B1 |
6511475 | Altshuler et al. | Jan 2003 | B1 |
6514243 | Eckhouse et al. | Feb 2003 | B1 |
6514248 | Eggers et al. | Feb 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6533775 | Rizoiu et al. | Mar 2003 | B1 |
6544259 | Tsaliovich | Apr 2003 | B1 |
6544261 | Ellsberry et al. | Apr 2003 | B2 |
6558653 | Andersen et al. | May 2003 | B2 |
6572637 | Yamazaki et al. | Jun 2003 | B1 |
6582429 | Krishnan et al. | Jun 2003 | B2 |
6594905 | Furst et al. | Jul 2003 | B2 |
6595990 | Weinstein et al. | Jul 2003 | B1 |
6597946 | Avrahami | Jul 2003 | B2 |
6602245 | Thiberg | Aug 2003 | B1 |
6611706 | Avrahami | Aug 2003 | B2 |
6612819 | Furst et al. | Sep 2003 | B1 |
6618620 | Freundlich et al. | Sep 2003 | B1 |
6620158 | Ronci | Sep 2003 | B2 |
6629974 | Penny et al. | Oct 2003 | B2 |
6632002 | Chubb et al. | Oct 2003 | B1 |
6632220 | Eggers et al. | Oct 2003 | B1 |
6637877 | Hartley et al. | Oct 2003 | B1 |
6662054 | Kreindel et al. | Dec 2003 | B2 |
6663620 | Altshuler et al. | Dec 2003 | B2 |
6676655 | McDaniel | Jan 2004 | B2 |
6702808 | Kreindel | Mar 2004 | B1 |
6708060 | Avrahami et al. | Mar 2004 | B1 |
6711435 | Avrahami | Mar 2004 | B2 |
6719754 | Underwood et al. | Apr 2004 | B2 |
6723092 | Brown et al. | Apr 2004 | B2 |
D490156 | Fischer et al. | May 2004 | S |
D490526 | Jonsen | May 2004 | S |
6740079 | Eggers et al. | May 2004 | B1 |
6743211 | Prausnitz et al. | Jun 2004 | B1 |
6749626 | Bhat et al. | Jun 2004 | B1 |
6758845 | Weckwerth et al. | Jul 2004 | B1 |
6761729 | Babaev | Jul 2004 | B2 |
6770069 | Hobart et al. | Aug 2004 | B1 |
6773431 | Eggers et al. | Aug 2004 | B2 |
6780838 | Lipton et al. | Aug 2004 | B2 |
6795728 | Chornenky et al. | Sep 2004 | B2 |
RE38634 | Westerhof et al. | Oct 2004 | E |
6887260 | McDaniel | May 2005 | B1 |
6889090 | Kreindel | May 2005 | B2 |
6893435 | Goble | May 2005 | B2 |
6905496 | Ellman et al. | Jun 2005 | B1 |
6918907 | Kelly et al. | Jul 2005 | B2 |
6974450 | Weber et al. | Dec 2005 | B2 |
6997923 | Anderson et al. | Feb 2006 | B2 |
7006874 | Knowlton et al. | Feb 2006 | B2 |
7013179 | Carter et al. | Mar 2006 | B2 |
7022121 | Stern et al. | Apr 2006 | B2 |
7077840 | Altshuler et al. | Jul 2006 | B2 |
7115123 | Knowlton et al. | Oct 2006 | B2 |
7115124 | Xiao | Oct 2006 | B1 |
7118563 | Weckwerth et al. | Oct 2006 | B2 |
7141049 | Stern et al. | Nov 2006 | B2 |
7153298 | Cohen | Dec 2006 | B1 |
7164942 | Avrahami et al. | Jan 2007 | B2 |
7204832 | Altshuler et al. | Apr 2007 | B2 |
7234239 | Saito et al. | Jun 2007 | B2 |
7238183 | Kreindel | Jul 2007 | B2 |
7266414 | Cornelius et al. | Sep 2007 | B2 |
7275819 | Bleau | Oct 2007 | B2 |
7278991 | Morris et al. | Oct 2007 | B2 |
7278993 | Kelly et al. | Oct 2007 | B2 |
7416550 | Protsenko et al. | Aug 2008 | B2 |
7435247 | Woloszko et al. | Oct 2008 | B2 |
7494488 | Weber | Feb 2009 | B2 |
7517344 | Van Hal et al. | Apr 2009 | B2 |
7601149 | DiCarlo et al. | Oct 2009 | B2 |
7713266 | Elkins et al. | May 2010 | B2 |
7771419 | Carmel et al. | Aug 2010 | B2 |
7824394 | Manstein | Nov 2010 | B2 |
7935107 | Altshuler et al. | May 2011 | B2 |
7963985 | Minamoto et al. | Jun 2011 | B2 |
8021360 | Dunning et al. | Sep 2011 | B2 |
8034052 | Podhajsky | Oct 2011 | B2 |
8109927 | Kelly et al. | Feb 2012 | B2 |
8128622 | Podhajsky et al. | Mar 2012 | B2 |
8133216 | Knopp et al. | Mar 2012 | B2 |
8135475 | Kreindel et al. | Mar 2012 | B2 |
8157807 | Ferren et al. | Apr 2012 | B2 |
8202268 | Wells et al. | Jun 2012 | B1 |
8206381 | Lischinsky et al. | Jun 2012 | B2 |
8216215 | Flyash et al. | Jul 2012 | B2 |
8235989 | Palanker et al. | Aug 2012 | B2 |
8292882 | Danek et al. | Oct 2012 | B2 |
8506564 | Long et al. | Aug 2013 | B2 |
20010007068 | Ota et al. | Jul 2001 | A1 |
20020035363 | Edwards et al. | Mar 2002 | A1 |
20020058936 | Avrahami et al. | May 2002 | A1 |
20020104543 | Hollander et al. | Aug 2002 | A1 |
20020120256 | Furuno et al. | Aug 2002 | A1 |
20020120260 | Morris et al. | Aug 2002 | A1 |
20020120261 | Morris et al. | Aug 2002 | A1 |
20020128641 | Underwood et al. | Sep 2002 | A1 |
20020128648 | Weber et al. | Sep 2002 | A1 |
20020143373 | Courtnage et al. | Oct 2002 | A1 |
20020147384 | Uchikubo | Oct 2002 | A1 |
20020173780 | Altshuler et al. | Nov 2002 | A1 |
20020183245 | Hasan et al. | Dec 2002 | A1 |
20020190337 | House et al. | Dec 2002 | A1 |
20020198575 | Sullivan | Dec 2002 | A1 |
20030004499 | McDaniel | Jan 2003 | A1 |
20030032900 | Ella | Feb 2003 | A1 |
20030032950 | Altshuler et al. | Feb 2003 | A1 |
20030055413 | Altshuler et al. | Mar 2003 | A1 |
20030055414 | Altshuler et al. | Mar 2003 | A1 |
20030097162 | Kreindel | May 2003 | A1 |
20030109871 | Johnson et al. | Jun 2003 | A1 |
20030135250 | Lauman et al. | Jul 2003 | A1 |
20030139790 | Ingle et al. | Jul 2003 | A1 |
20030195494 | Altshuler et al. | Oct 2003 | A1 |
20030199863 | Swanson et al. | Oct 2003 | A1 |
20030199946 | Gutwein | Oct 2003 | A1 |
20030216719 | Debenedictis et al. | Nov 2003 | A1 |
20040010250 | Manna et al. | Jan 2004 | A1 |
20040010298 | Altshuler et al. | Jan 2004 | A1 |
20040015161 | Lovewell | Jan 2004 | A1 |
20040015162 | McGaffigan | Jan 2004 | A1 |
20040064167 | Berry et al. | Apr 2004 | A1 |
20040133251 | Altshuler et al. | Jul 2004 | A1 |
20040143308 | Lundahl et al. | Jul 2004 | A1 |
20040147984 | Altshuler et al. | Jul 2004 | A1 |
20040167501 | Island et al. | Aug 2004 | A1 |
20040181216 | Kelly et al. | Sep 2004 | A1 |
20040186466 | Chornenky | Sep 2004 | A1 |
20040193234 | Butler | Sep 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040236320 | Protsenko et al. | Nov 2004 | A1 |
20040260210 | Ella et al. | Dec 2004 | A1 |
20040267252 | Washington et al. | Dec 2004 | A1 |
20050015042 | Sun et al. | Jan 2005 | A1 |
20050033286 | Eggers et al. | Feb 2005 | A1 |
20050043653 | Trimmer et al. | Feb 2005 | A1 |
20050049543 | Anderson et al. | Mar 2005 | A1 |
20050075573 | Park et al. | Apr 2005 | A1 |
20050085804 | McGaffigan | Apr 2005 | A1 |
20050096646 | Wellman et al. | May 2005 | A1 |
20050137654 | Hoenig et al. | Jun 2005 | A1 |
20050137655 | MacFarland et al. | Jun 2005 | A1 |
20050143793 | Korman et al. | Jun 2005 | A1 |
20050147137 | Slatkine | Jul 2005 | A1 |
20050149012 | Penny et al. | Jul 2005 | A1 |
20050177139 | Yamazaki et al. | Aug 2005 | A1 |
20050288680 | Ingle et al. | Dec 2005 | A1 |
20060009763 | Goble et al. | Jan 2006 | A1 |
20060036300 | Kreindel | Feb 2006 | A1 |
20060047281 | Kreindel | Mar 2006 | A1 |
20060095096 | DeBenedictis et al. | May 2006 | A1 |
20060149343 | Altshuler et al. | Jul 2006 | A1 |
20060184024 | Da Silva et al. | Aug 2006 | A1 |
20060200213 | McDaniel | Sep 2006 | A1 |
20060206173 | Gertner et al. | Sep 2006 | A1 |
20060224217 | Burgmann et al. | Oct 2006 | A1 |
20060231568 | Lynn et al. | Oct 2006 | A1 |
20060247741 | Hsu et al. | Nov 2006 | A1 |
20060253112 | Suarez et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060271028 | Altshuler et al. | Nov 2006 | A1 |
20070016117 | Sliwa et al. | Jan 2007 | A1 |
20070038206 | Altshuler et al. | Feb 2007 | A1 |
20070093798 | Debenedictis et al. | Apr 2007 | A1 |
20070106349 | Karni et al. | May 2007 | A1 |
20070129711 | Altshuler et al. | Jun 2007 | A1 |
20070129771 | Kurtz et al. | Jun 2007 | A1 |
20070142881 | Hennings | Jun 2007 | A1 |
20070191821 | Boxer Wachler | Aug 2007 | A1 |
20070191827 | Lischinsky et al. | Aug 2007 | A1 |
20070197895 | Nycz et al. | Aug 2007 | A1 |
20070198004 | Altshuler et al. | Aug 2007 | A1 |
20070206275 | Hemmer et al. | Sep 2007 | A1 |
20070213696 | Altshuler et al. | Sep 2007 | A1 |
20070239142 | Altshuler et al. | Oct 2007 | A1 |
20070239143 | Altshuler et al. | Oct 2007 | A1 |
20070239152 | Trezon | Oct 2007 | A1 |
20070264626 | DeBenedictis et al. | Nov 2007 | A1 |
20070271714 | Adam et al. | Nov 2007 | A1 |
20080051680 | Luebcke | Feb 2008 | A1 |
20080071334 | Hoenig et al. | Mar 2008 | A1 |
20080082090 | Manstein | Apr 2008 | A1 |
20080123238 | Campos et al. | May 2008 | A1 |
20080125658 | Lee et al. | May 2008 | A1 |
20080139901 | Altshuler et al. | Jun 2008 | A1 |
20080154247 | Dallarosa et al. | Jun 2008 | A1 |
20080183167 | Britva et al. | Jul 2008 | A1 |
20080188846 | Palanker et al. | Aug 2008 | A1 |
20080200910 | Burger et al. | Aug 2008 | A1 |
20080214988 | Altshuler et al. | Sep 2008 | A1 |
20080215124 | Wagenaar et al. | Sep 2008 | A1 |
20080221504 | Aghion | Sep 2008 | A1 |
20080294153 | Allshuler et al. | Nov 2008 | A1 |
20080306476 | Hennings et al. | Dec 2008 | A1 |
20090036953 | Gustavsson | Feb 2009 | A1 |
20090043293 | Pankratov et al. | Feb 2009 | A1 |
20090054743 | Stewart | Feb 2009 | A1 |
20090105706 | Livneh | Apr 2009 | A1 |
20090112205 | McGill et al. | Apr 2009 | A1 |
20090119834 | Kneale et al. | May 2009 | A1 |
20090171341 | Pope et al. | Jul 2009 | A1 |
20090182315 | Zigan et al. | Jul 2009 | A1 |
20090192503 | Epshtein et al. | Jul 2009 | A1 |
20090222023 | Boone et al. | Sep 2009 | A1 |
20090234341 | Roth | Sep 2009 | A1 |
20090234342 | Ely et al. | Sep 2009 | A1 |
20090240310 | Kennedy | Sep 2009 | A1 |
20090299361 | Flyash et al. | Dec 2009 | A1 |
20100010480 | Mehta et al. | Jan 2010 | A1 |
20100063565 | Beerwerth et al. | Mar 2010 | A1 |
20100145321 | Altshuler et al. | Jun 2010 | A1 |
20100185193 | Kreindel | Jul 2010 | A1 |
20100185194 | Kreindel | Jul 2010 | A1 |
20100198134 | Eckhouse | Aug 2010 | A1 |
20100211055 | Eckhouse et al. | Aug 2010 | A1 |
20100249772 | Mehta et al. | Sep 2010 | A1 |
20100274329 | Bradley et al. | Oct 2010 | A1 |
20110112405 | Barthe et al. | May 2011 | A1 |
20110137386 | Kreindel | Jun 2011 | A1 |
20110166559 | Eckhouse et al. | Jul 2011 | A1 |
20110196363 | Kreindel | Aug 2011 | A1 |
20120016354 | Epshtein et al. | Jan 2012 | A9 |
20120022512 | Vaynberg | Jan 2012 | A1 |
20120022518 | Levinson | Jan 2012 | A1 |
20120123397 | Epshtein et al. | May 2012 | A1 |
20120143178 | Mehta | Jun 2012 | A9 |
20120143270 | Mehta | Jun 2012 | A1 |
20120197242 | Rosenberg | Aug 2012 | A1 |
20120290023 | Boyden et al. | Nov 2012 | A1 |
20130144280 | Eckhouse et al. | Jun 2013 | A1 |
20130289679 | Eckhouse et al. | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
2495005 | Feb 2004 | CA |
1078383 | Nov 1993 | CN |
0528055 | Feb 1993 | EP |
0569670 | Nov 1993 | EP |
0743029 | Jul 2002 | EP |
0824019 | Nov 2002 | EP |
1852060 | Nov 2007 | EP |
2125986 | Aug 1982 | GB |
2202442 | Sep 1988 | GB |
04299998 | Oct 1992 | JP |
06113920 | Apr 1994 | JP |
11132843 | Dec 1999 | JP |
2003034630 | Feb 2003 | JP |
WO-8302389 | Jul 1983 | WO |
WO-9321992 | Nov 1993 | WO |
WO-9909143 | Feb 1999 | WO |
WO-9909143 | Feb 1999 | WO |
WO-9934867 | Jul 1999 | WO |
WO-02078644 | Oct 2002 | WO |
WO-02078644 | Oct 2002 | WO |
WO-02094116 | Nov 2002 | WO |
WO-03039367 | May 2003 | WO |
WO-03039367 | May 2003 | WO |
WO-2006128034 | Nov 2006 | WO |
Entry |
---|
Acne Clearance, LHE Clinical Casebook, Radiancy: Lighting the Future of Skin Care, © 2002. |
Acne Star web page, describing “How to use get rid of Acne Treatment”, printed May 5, 2005. |
Acne Star web page, describing Clinical Studies, “The Treatment of acne vulgaris with a novel device that uses Gallium—Nitride diode light”, printed May 5, 2005. |
Aesthetic Buyers Guide: The Leading Cosmetic Practice Resource, Jan./Feb. 2004, vol. 7, No. I. |
Bollen, CM. et al., “Full- versus partial-mouth disinfection in the treatment of periodontal infections. A pilot study: long-tenn microbiological observations”, J Clin Periodontol Oct. 1996;23(10):960-70 (Abstract). |
Bollen, CM. et al., “Full- versus partial-mouth disinfection in the treatment of periodontal infections. A pilot study: long-term microbiological observations”. J Clin Periodontol Oct. 1996;23(10):960-70 (Abstract). |
Bollen, CM. et al., The effect of a one-stage full-mouth disinfection on different intra-0ral niches. Clinical and microbiological observations•. J Clin Periodontol Jan. 1998;25(1 ):56-66 (Abstract). |
Bollen, CM. et al., “The effect of a one-stage full-mouth disinfection on different intra-oral niches. Clinical and microbiological observations”, J Clin Periodontol Jan. 1998;25(1 ):56-66 (Abstract). |
Calderhead, R. Glen, “The Photobiology of LED Phototherapy”. |
Calderl-Iead, R. Glen, “The Photobiology of LED Phototherapy”. |
Charakida et al., “Phototherapy in the Treatment of Acne Vulgaris, What is the Role?”, Am. J. Clin. Dermatol 2004: 5(4): 211-216. |
Cohen L.R., “What causes bad breath?”, University of Toronto; webpage (printed before Nov. 2, 2004). |
Cohen Lr., “What causes bad breath?”, University of Toronto; webpage (printed before Nov. 2, 2004). |
Coventry et al. (2000) “ABC of oral health: Periodontal disease” British Medical Journal, 321, 36-39. |
De Soete, M. et al .. One-stage full-mouth disinfection. Long-term microbiological results analyzed by checker board DNA-DNA hybridization•, J Periodontol Mar. 2001; 72(3):374-82 (Abstract). |
De Soete, M. et al., “One-stage full-mouth disinfection. Long-term microbiological results analyzed by checker board DNA-DNA hybridization”, J Periodontol Mar. 2001; 72(3):374-82 (Abstract). |
Elman M. et al., “The effective treatment of acne vulgaris by a high-intensity, narrow bank 405-420 nm light source”, Cosmetic & Laser Ther 2003; 5: 111-116. |
Elman M. et al., The effective treatment of acne vulgaris by a high-intensity, narrow bank 405-420 nm light source•, Cosmetic & Laser Ther 2003; 5: 111-116. |
Flow Control Network web page, “Mini Diaphragm Pumps for Precision Dispensing” by Ping Lin, printed Aug. 2, 2005. |
Friedberg J.S. et al., “Antibody-Targeted Photolysis Bacteriocidal Effects of Sn (IV) Chlorin e6-0extran-Monoclonal Antibody Conjugates”, Annals New York Academy of Sciences 618:383-393, 1991. |
Friedberg JS et al., “Antibody-Targeted Photolysis Bacteriocidal Effects of Sn (IV) Chlonn e6-Dextran-Monoclonal Antibody Conjugates”, Annals New York Academy of Sciences 618:383-393, 1991. |
Greenstein G., Full-mouth therapy versus individual quadrant root planning: a critical commentary, J Periodontol Jul. 2002;73(7):797-812 (Abstract). |
Greenstein G., Full-mouth therapy versus individual quadrant root planning: a critical commentary, JPeriodontol Jul. 2002;73(7):797-812 (Abstract). |
Guidelines for Limiting Exposure to Time-Varying Electric, Magnetic, and Magnetic Fields (Up to 300 GHz), International Commission on Non-Ionizing Radiation Protection, ICNIRP Guidelines, Apr. 1998, vol. 7 4, No. 4, pp. 494-522. |
Hamblin, M. et al., “Rapid Control of Wound Infections by Targeted Photodynamic Therapy Monitored by In Vivo Bioluminescence Imagining”, Photochemistry and Photobiology, 2002, 75(1 ): 51-57. |
Hamblin, M. et al., Rapid Control of Wound Infections by Targeted Photodynamic Therapy Monitored by In Vivo Biluminescence Imagining•, Photochemistry and Photobiology, 2002, 75(1): 51-57. |
Komerik et al. (2003) “In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model” Antimicrobial Agents and Chemotherapy, 47(3), 932-940. |
Krespi, et al. (2005) “Lethal photosensitization of oral pathogens via red-filtered halogen lamp” Oral Diseases, 11(S1), 92-95. |
Krespi, et al. (2005) “Lethal photosensitization of oral pathogens via red-filtered halogen larnp” Oral Diseases, 11(S1 ), 92-95. |
Malik, Z. et al., “New Trends in Photobiology (Invited Review) Bactericidal Effects of Photoactivated Porphyrins—An Alternative Approach to Antimicrobial Drugs”, Journal of Photochemistry and Photobiology, B: Biology, May 1, 1990}—281-293. |
Malik, Z. et al., “New Trends in Photobiology (Invited Review) Bactericidal Effects of Photoactivated Porphyrins • An Alternative Approach to Antimicrobial Drugs”, Journal of Photochemistry and Photobiology, B: Biology, 5 J.19901—281-293. |
Matevski D. et al., “Lethal photosensitization of periodontal pathogens by a red-filtered Xenon lamp in invitro”, J. Periodont. Res. 2003; 38:428-435. |
Matevski D. et al., “Lethal photosensitization of periodontal pathogens by a red-filtered Xenon lamp in invitro”, JPeriodont. Res. 2003. 38:428-435. |
Matevski D. et al., Sensitivity of Porphyromonas gingivalis to Light-Activated Toluidine Blue o•. University of Toronto, Faculty of Dentistry; Slide presentation (presented before Nov. 15, 2002). |
Matevski D. et al., “Sensitivity of Porphyromonas gingivalis to Light-Activated Toluidine Blue O”, University of Toronto, Faculty of Dentistry; Slide presentation (presented before Nov. 15, 2002). |
Meisel et al. (2005) Photodynamic therapy for periodontal diseases: State of the are• J. Photochem. Photobiol., 79, 159-170. |
Meisel etal. (2005) “Photodynamic therapy for periodontal diseases: State of the are” J. Photochem. Photobiol., 79, 159-170. |
Mongardini, C. et al., One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized ear l y-0nset periodontitis. I. Long-tenn clinical observations•, J Periodontol Jun. 1999;70(6):632-45 —[Abstrac!)—. |
Mongardini, C. et al., “One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. I. Long-term clinical observations”, J Periodontol Jun. 1999;70(6):632-45 1Abstrac!2.—. |
Morton C.A. et al., An open study to determine the efficacy of blue light in the treatment of mild to moderate acne: preliminary data (publication status unknown). |
Nakano et al. (2002) “Correlation between oral malodor and periodontal bacteria” Microbes Infect., 4(6), 679-683. |
Nakano et al. (2002) “Correlation between oral malodor and periodontal bacteria” Microbes Infect., 4(6). 679-683. |
Ondine Biopharma web page—printed Oct. 15, 2002. |
Papageorgiou et al., “Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris”, British Journal of Dermatology 2000: 142: 973-978. |
Pharmaceutical description, Levulan® Kerastick arninolevulinic acid I-IC!) for Topical Solution, 20′X. |
Pharmaceutical description, Levulan® Kerastick •aminolevulinic acid HCI) for Topical Solution, 20%. |
Quirynen, M. et al. Fuli- vs. partial-mouth disinfection in the treatment of periodontal infections: short-tennclinical and microbiological observations•. J Dent Res Aug. 1995;74(8):1459-67 (Abstract). |
Quirynen, M. et al. “Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations”, J Dent Res Aug. 1995;74(8):1459-67 (Abstract). |
Quirynen, M. et al., “One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized ear l y-onset periodontitis. II. Long-term impact on microbial load”, J Periodontol Jun. 1999;70(6):646-56 (Abstract). |
Quirynen, M. et al., “The effect of a 1-stage full-mouth disinfection on oral malodor and microbial colonization of the tongue in periodontitis. A pilot study”, J Periodontol Mar. 1998;69(3):374-82 (Abstract). |
Quirynen, M. et al., “The intra-oral translocation of periodontopathogens jeopardises the outcome of periodontal therapy”, Journal of Clinical Periodontology, Jun. 2001, vol. 28, Issue 6, p. 499 (Abstract). |
Quirynen, M. et al., The role of chlorhexidine in the one-stage full-mouth disinfection treatment of patients with advanced adults periodontitis. Long-term clinical and microbiological observations•. J Clin Periodontol 2000 A1.IQ;27.{fil:579-89 J—Abstrac!)—. |
Quirynen, M. et al., “The role of chlorhexidine in the one-stage full-mouth disinfection treatment of patients with advanced adult periodontitis. Long-term clinical and microbiological observations”, J Clin Periodontol 2000 A1!JL2˜579-89 J—Abstrac—!). |
Quirynen. M. et al., “One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. II. Long-term impact on microbial load”, J Peridontol Jun. 1999;70(6):646-56 J—Abstrac!2.—. |
Sanz et al. (2001) “Fundamentals of breath malodour” Journal of Contemporary Dental Practice, 2(4 ), 1-13. |
Sanz et al. (2001) “Fundamentals of breath malodour” Journal of Contemporary Dental Practice, 2(4), 1-13. |
Sarkar et al. (1993) “Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis” J. Periodont. Res , 28, 204-21 O. |
Sarkar et al. (1993) “Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis” J. Periodont. Res., 28, 204-210. |
Search results from Delphion web site, dated Nov. 22, 2005. |
Skin91 I .com web page regarding Peter Thomas Roth Clinical Acne Medication, acne treatment-Benzoyl Peroxide 5% pbp5, printed Aug. 19, 2005. |
Skin91 I .corn web page regarding Peter Thomas Roth Clinical Acne Medication, acne treatment-Benzoyl Peroxide 5% pbp5, printed Apr. 19, 2005. |
Soukos et al. (1998) “Targeted antimicrobial photochemotherapy”, Antimicrobial Agents and Chemotherapy 42( 10 ), 2595-2601. |
Soukos et al. (1998) “Targeted antimicrobial photochemotherapy”, Antimicrobial Agents and Chemotherapy 42(10), 2595-2601. |
Spire Awarded Contract for Ear Surgery Laser—Press Release Aug. 23, 2002. |
Temperatures.com web page, “Thermistor Temperature Sensors,” printed Aug. 2, 200. |
Temperatures.corn web page, “Thermistor Temperature Sensors,” printed Aug. 2, 200. |
Vandekerckhove, BN. et al., “Full- versus partial-mouth disinfection in the treatment of periodontal infections. Long-term clinical observations of a pilot study”, J Periodontol Dec. 1996;67(12):1251-9 (Abstract). |
Vandekerckhove, BN. et al.. “Full- versus partial-mouth disinfection in the treatment of periodontal infections. Long-term clinical observations of a pilot study”, J Periodontal Dec. 1996;67(12):1251-9 (Abstract). |
Wainwright M., Photodynamic antimicrobial chemotherapy (PACT), Journal of Antimicrobial Chemotherapy (1998) 42, 13-28. |
Wilson (2005) “Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infection” Photochem. Photobiol. Sci . . . 3, 412-418. |
Wilson (2005) “Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infection” Photochem. Photobiol. Sci., 3, 412-418. |
Wilson et al. (1995) “Bacteria in supragingival plaque samples can be killed by low-power laser light in the presence of a photosensitizer” J. Appl. Bacteriol . . . 78, 569-574. |
Wilson et al. (1995) “Bacteria in supragingival plaque samples can be killed by low-power laser light in the presence of a photsensitizer” J. Appl. Bacteriol., 78, 569-574. |
Wood, et al. (1999) “An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo” J. Photochem. Photogiol. B: Biol . . . 50, 1-7. |
Wood, et al. (1999) “An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilrns formed in vivo” J. Photochem. Photogiol. B: Biol., 50, 1-7. |
www.lightbioscience.com web page, Gentle Waves Cosmcceuticals, printed Jul. 29, 200. |
www.lightbioscience.com web page, Gentle Waves LED Photomodulation Fact Sheet, printed Jul. 29, 2005. |
www.lightbioscience.com web page, GentleWaves Cosmeceuticals, printed Jul. 29, 200. |
www.lightbioscience.com web page, GentleWaves LED Photomodulation Fact Sheet, printed Jul. 29, 2005. |
Guidelines for Limiting Exposure to Time-Varying Electric, Magnetic, and Electromagnetic Fields (Up to 300 GHz), International Commission on Non-Ionizing Radiation Protection, ICNIRP Guidelines, Apr. 1998, vol. 74, No. 4, pp. 496-522. |
PCT/IL11/00256 International Search Report. |
PCT/IL11/00170 International Search Report. |
PCT/IL10/00751 International Search Report. |
PCT/IL10/00557 International Search Report. |
PCT/IL10/00173 International Search Report. |
PCT/IL09/00693 International Search Report. |
PCT/IL09/00033 International Search Report. |
Number | Date | Country | |
---|---|---|---|
20120041431 A1 | Feb 2012 | US |
Number | Date | Country | |
---|---|---|---|
61208621 | Feb 2009 | US |